These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6851947)

  • 1. Estrogen and antiestrogen binding to different forms of the molybdate-stabilized estrogen receptor.
    Ruh MF; Brzyski RG; Strange L; Ruh TS
    Endocrinology; 1983 Jun; 112(6):2203-5. PubMed ID: 6851947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and antiestrogen binding to rat uterine and pituitary estrogen receptor: evidence for at least two physicochemical forms of the estrogen receptor.
    Jasper TW; Ruh MF; Ruh TS
    J Steroid Biochem; 1985 Nov; 23(5A):537-45. PubMed ID: 4079371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of two forms of molybdate-stabilized estrogen receptor.
    Ruh MF; Ruh TS
    Endocrinology; 1984 Oct; 115(4):1341-9. PubMed ID: 6479095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of [3H]estradiol--and [3H]H1285-receptor complexes: effect of salt versus ATP on molybdate-stabilized estrogen receptors.
    Singh RK; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Aug; 21(2):205-8. PubMed ID: 6482431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
    Singh RK; Ruh MF; Butler WB; Ruh TS
    Endocrinology; 1986 Mar; 118(3):1087-95. PubMed ID: 3948766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of [3H]estradiol- and [3H]H1285-receptor complexes to rabbit uterine chromatin.
    Singh RK; Ruh MF; Ruh TS
    Biochim Biophys Acta; 1984 Jul; 800(1):33-40. PubMed ID: 6743683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
    Hutchens TW; McNaught RW; Yip TT; Suzuki T; Li CM; Besch PK
    Mol Endocrinol; 1990 Feb; 4(2):255-67. PubMed ID: 2330004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the form of the salt-transformed estrogen receptor when bound by estrogen versus antiestrogen.
    Ruh MF; Turner JW; Paulson CM; Ruh TS
    J Steroid Biochem; 1990 Aug; 36(6):509-16. PubMed ID: 2214766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiestrogen versus antiprogestin on transformed and nontransformed steroid receptors.
    Turner JW; Ruh MF; Ward DT; Ruh TS
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):197-203. PubMed ID: 2004041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous deoxyribonucleic acid-binding forms of rabbit uterine progesterone receptor.
    Lamb DJ; Bullock DW
    Endocrinology; 1984 May; 114(5):1833-40. PubMed ID: 6714169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.
    Faye JC; Fargin A; Bayard F
    Endocrinology; 1986 Jun; 118(6):2276-83. PubMed ID: 3698914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of non-activated and activated estrogen- and antiestrogen-receptor complexes by high performance ion exchange chromatography.
    Myatt L; Wittliff JL
    J Steroid Biochem; 1986 May; 24(5):1041-8. PubMed ID: 3724142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the radiolabelled high-affinity anti-oestrogen [3H]H1285 with the cytoplasmic oestrogen receptor.
    Keene JL; Sweet F; Ruh MF; Ruh TS
    Biochem J; 1984 Feb; 217(3):819-26. PubMed ID: 6712598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of steroid hormone receptors with ion-exchange fast protein liquid chromatography.
    Brinkmann AO; Bolt-de Vries J; De Boer W; Lindh LM; Mulder E; van der Molen HJ
    J Steroid Biochem; 1985 Jan; 22(1):85-90. PubMed ID: 3871882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal inactivation and molecular forms of the estrogen receptor: effects of molybdate.
    Joab I; Redeuilh G; Secco C; Radanyi C; Baulieu EE; Richard-Foy H
    Biochem Biophys Res Commun; 1981 Nov; 103(2):505-10. PubMed ID: 7332556
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of uterine estrogen receptor transformation by sodium molybdate.
    Shyamala G; Leonard L
    J Biol Chem; 1980 Jul; 255(13):6028-31. PubMed ID: 7391003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.